MAPT and Alzheimer disease: Similarly, bioactive compounds such as quercetin and curcumin, as well as protein modulators like tyrosine phosphatase-2 (SHP2), have been efficiently packaged within EVs, providing a therapeutic thrust against hyperphosphorylated tau and mitochondrial dysfunction associated with AD [151–153].